미만성 거대 B세포 림프종 환자의 한의약치료 증례보고
Case of a Diffuse Large B-Cell Lymphoma Patient Treated with Traditional Korean Medicine Treatment
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
This case report that the therapeutic effects of traditional Korean medicine(TKM) treatment on the tumor response in a diffuse large B-cell lymphoma(DLBL) patient. A patient was treated by acupuncture, pharmacopuncture, moxibustion, cupping and herbal medicine once a week at least for 12 months. we evaluated the grade of chief complaints and performed blood tests and sonography, abdominal CT periodically. After 1 month administration with TKM treatment, the symptoms of the patient vanished obviously. the size of inguinal lymphoma decreased gradually through 3 months. then from 3 to 10 months, the size of inguinal lymphoma remained as it is. TKM treatment was maintained continuously. in the abdomino-pelvic CT performed after 12 months, the patient didn’t complain any symptom and the size of inguinal lymphoma decreased a little again. This case study supports that TKM treatments may have a efficacy in treating diffuse large B-cell lymphoma(DLBL) patients.
Abstract
This case report that the therapeutic effects of traditional Korean medicine(TKM) treatment on the tumor response in a diffuse large B-cell lymphoma(DLBL) patient. A patient was treated by acupuncture, pharmacopuncture, moxibustion, cupping and herbal medicine once a week at least for 12 months. we evaluated the grade of chief complaints and performed blood tests and sonography, abdominal CT periodically. After 1 month administration with TKM treatment, the symptoms of the patient vanished obviously. the size of inguinal lymphoma decreased gradually through 3 months. then from 3 to 10 months, the size of inguinal lymphoma remained as it is. TKM treatment was maintained continuously. in the abdomino-pelvic CT performed after 12 months, the patient didn’t complain any symptom and the size of inguinal lymphoma decreased a little again. This case study supports that TKM treatments may have a efficacy in treating diffuse large B-cell lymphoma(DLBL) patients.
참고문헌 (25)
- The Non-Hodgkin`s Lymphomal Classification Project, "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin`s lymphoma", Blood, 89, pp.3909~3918 (1997)
- 한지숙, "한국의 악성림프종에 관한 통계적관찰", 대한혈액학회지, 30, pp.197~203 (1995)
- Smith, A., "Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network", British Journal of Cancer, 105(11), pp.1684~1692 (2001)
- Smith, A., "Haematological Malignancy Research Network", British Journal of Haematology, 148(5), pp.739~753 (2010)
- Arnold S. Freeman, "Aster Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma", ~ (2012)
- Swerdlow, S. H., "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues", pp.233~237 (2008), IARC Lyon
- Sehn, L. H., "High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma", Blood, 109, pp.1857~1861 (2007)
- 김현정, "미만성 거대 B세포 림프종의 포괄적 고찰", Journal of Soonchunhyang Medical Science, 14(3), pp.467~476 (2009)
- Giantonio, B. J., "The role of the Eastern Cooperative Oncology Group in establishing standards of cancer care : over 50 years of progress through clinical research", Semin Oncol, 35(5), pp.494~506 (2008)
- 박재갑, "종양학(Oncology)", pp.772~ (2009), 일조각
- Pasqualucci, L., "Hypermutation of multiple protooncogenes in B-cell diffuse large-cell lymphomas", Nature, 412, pp.341~346 (2001)
- Sweet, D. L., "Survival of patients with localized diffuse histiocytic lymphoma", Blood, 58, pp.1218~1223 (1981)
- Nissen, N.I., "randomized study of radiotherapy alone compared with chemotherapy versus radiotherapy plus chemotherapy in stageⅠ-Ⅱ non0hodgkin`s lymphomas", Cancer, 52, pp.1~7 (1980)
- Coiffier, B., "CHOP chemotherapy plus rituximalb compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma", N Engl J Med, 346, pp.235~242 (2002)
- Fisher, R. I., "Comparison of a standard regimen(CHOP) with three intensive chemotherapy regiments for advanced non-Hodgkin's lymphoma", Nengl J Med, 328, pp.1002~1006 (1993)
- Feugier, P., "Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte", J clin Oncol, 23, pp.4117~4126 (2005)
- Pfeundschuh, M., "Two-weekly or 3-weekly CHOP cheomtherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL", Blood, 104, pp.634~641 (2004)
- 홍성일, "인간 암세포주에 대한 건칠 추출물의 선택적 세포독성 효과", 석사, 내과학(한의학), pp.2007
- 김재용, "인체 대장암 세포주 SW480에서 재배 와송의 세포 사멸 유도 효과", 한국식품과학회지, 44(3), pp.317~323 (2012), 한국식품과학회[DOI]
- 김진성, "와송의 수종 암세포에 대한 항암작용 연구", 대한한방내과학회지, 26(2), pp.333~340 (2005), 대한한방내과학회
- 임좌빈, "와송(瓦松)이 암에 미치는 효능", 대한한의학회지, 4(1) (1996)
- 윤경수, "瓦松이 만성 골수성 백혈병 세포주(K562)에서 세포사멸에 미치는 영향", 대한한방내과학회지, 27(1), pp.166~177 (2006), 대한한방내과학회
- 박승찬, "Akt 활성억제 및 Caspase-3의 활성화를 통한 삼칠근 열수 추출물의 인간 폐암세포에서의 세포사멸 유도", 박사, 내과학(한의학), pp.2009
- Savage, K. J., "ALK-ana-plastic large-cell lymphoma is clinically and im-munopheno-typically different from both ALK+ALCL and peripheral T-cell lymphoma, not other-wise specified: report form the International Peripheral T-cell Lymphoma Project", Blood, 111(12), pp.5496~5504 (2008)
- 김시내, "미만성 거대 B세포 림프종 환자 치료 후 절대림프구수 감소율의 예후적 가치", 대한내과학회지, 76(1), pp.52~59 (2009), 대한내과학회